Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Free Report) insider Catriona Yale sold 617 shares of the stock in a transaction on Wednesday, September 13th. The shares were sold at an average price of $50.34, for a total transaction of $31,059.78. Following the completion of the sale, the insider now directly owns 46,010 shares in the […]
Ambrx Biopharma Inc. (NYSE:AMAM – Get Free Report)’s share price rose 7.7% on Tuesday following insider buying activity. The company traded as high as $11.24 and last traded at $11.04. Approximately 361,206 shares traded hands during mid-day trading, a decline of 81% from the average daily volume of 1,892,357 shares. The stock had previously closed […]
Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the seven analysts that are presently covering the company, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average twelve-month target price […]
Commodore Capital LP boosted its position in shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN – Free Report) by 8.4% in the 1st quarter, HoldingsChannel reports. The fund owned 2,189,659 shares of the company’s stock after acquiring an additional 169,493 shares during the period. Viridian Therapeutics accounts for about 8.5% of Commodore Capital LP’s portfolio, making the […]
Logos Global Management LP cut its holdings in FibroGen, Inc. (NASDAQ:FGEN – Free Report) by 42.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 300,000 shares of the biopharmaceutical company’s stock after selling 225,000 shares during the […]